Related Experiment Videos
Extracapsular cataract extraction in Fuchs' heterochromic iridocyclitis
1Department of Ophthalmology, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
American Journal of Ophthalmology
|September 15, 1989
Summary
Extracapsular cataract extraction with posterior chamber intraocular lens implantation is a safe and effective treatment for Fuchs
Area of Science:
- Ophthalmology
- Surgical Innovation
- Uveitis Management
Background:
- Fuchs' heterochromic iridocyclitis (FHI) is a chronic anterior uveitis often associated with cataract formation.
- Cataract extraction is frequently necessary in patients with FHI, but surgical outcomes can be variable.
- The role of intraocular lens (IOL) implantation in FHI requires further investigation.
Purpose of the Study:
- To evaluate the safety and efficacy of extracapsular cataract extraction (ECCE) in patients with FHI.
- To assess the outcomes of capsular-fixated posterior chamber intraocular lens (PCIOL) implantation in conjunction with ECCE for FHI.
- To determine the long-term visual results and complication rates associated with this surgical approach.
Main Methods:
- A retrospective study of 15 patients diagnosed with FHI.
- All patients underwent extracapsular cataract extraction.
- Ten patients received capsular-fixated posterior chamber intraocular lens implantation.
Main Results:
- A favorable clinical course was observed in all patients.
- Postoperative best-corrected visual acuity of 20/40 or better was achieved in 100% of patients.
- No major surgical, intraoperative, or postoperative complications were reported.
Conclusions:
- Extracapsular cataract extraction combined with capsular-fixated PCIOL implantation is a safe and effective surgical option for managing cataracts in patients with FHI.
- This surgical approach leads to favorable visual outcomes and a low complication rate.
- Further studies are warranted to confirm these findings in a larger cohort.